Ketek: profile and news

Canada: may be tie between Sanofi's Ketek, liver harm Feb 7, 2006
OTTAWA (Reuters) - The federal health ministry warned Canadians on Tuesday that there might be a link between the antibiotic Ketek, produced by France's Sanofi ... - Reuters

Liver patients warned about antibiotic Ketek Feb 7, 2006
TORONTO — The antibiotic Ketek should not be used by patients known to have liver problems, Health Canada advised Tuesday in interim recommendations on the ... - CTV.ca,

Antibiotic Ketek (Telithromycin) and Possible Association With ... Feb 7, 2006
OTTAWA, CANADA -- February 7, 2006 -- Health Canada is advising Canadians about a possible link between use of the antibiotic Ketek and potentially serious ... - DG News

Advisory - Antibiotic Ketek and possible association with liver ... Feb 7, 2006
7 /CNW Telbec/ - Health Canada is advising Canadians about a possible link between use of the antibiotic Ketek and potentially serious liver problems. ... - Canada NewsWire (press release),

Doctors link drug to liver disease Feb 4, 2006
A third patient developed severe liver problems but got well once he stopped taking the drug, Ketek, according to doctors at Carolinas Medical Center. ... - The State,

Liver injuries continue to plague the drug development system Feb 19, 2006
Take Ketek, for example, an antibiotic used to treat respiratory infections. In January, a report on the web site of the journal ... - RxPG NEWS,

Deadly germs getting even deadlier Mar 3, 2006
Wyeth's Tygacil and Sanofi-Aventis' Ketek have been touted as new classes, and though the distinction can be argued, both were definitely better at fighting ... - MSNBC

Sanofi-Aventis' Battered Charm Mar 1, 2006
We also see recent reports of liver disease risks affecting sales of the Ketek antibiotic. Vaccine sales will likely rise about 14% in 2006. ... - BusinessWeek

Viagra, insulin, & antibiotics, oh my Feb 2, 2006
The antibiotic telithromycin, sold under the name Ketek, recently has been associated with three cases of severe liver toxicity. ... - Bay Area Reporter,

Sanofi's Ketek antibiotic safety profile unchanged Jan 21, 2006
...is standing by its antibiotic Ketek, saying the drug's safety profile remains unchanged even though doctors have found three patients suffered severe liver ... - Reuters.uk,

Sanofi's Ketek antibiotic safety profile unchanged Jan 21, 2006
PARIS (Reuters) - French drugmaker Sanofi-Aventis SA is standing by its antibiotic Ketek, saying the drug's safety profile remains unchanged even though ... - Reuters

Sanofi's Ketek antibiotic safety profile unchanged Jan 21, 2006
PARIS, Jan 21 (Reuters) - French drugmaker Sanofi-Aventis SA (SASY.PA: Quote, Profile, Research) is standing by its antibiotic Ketek, saying the drug's safety ... - Reuters

Ketek (Telithromycin) Linked to Two Cases of Liver Failure and ... Jan 20, 2006
PHILADELPHIA, PA -- January 20, 2006 -- Three case reports of liver problems after taking the antibiotic telithromycin (Ketek®) are reported in Annals of ... - DG News

FDA Public Health Advisory: Ketek (Telithromycin) Tablets Jan 23, 2006
Medicine published an article on January 20 th reporting three patients who experienced serious liver toxicity following administration of Ketek (telithromycin ... - DG News

Sanofi-Aventis Under Limited Threat On Ketek Jan 23, 2006
1217 GMT [Dow Jones]--Sanofi-Aventis (SNY) is under marginal threat after the FDA's alert on Ketek, suggesting the drug's marketing may come under review, says ... - New Ratings

Sanofi Down After FDA Alert On Drug Ketek Jan 23, 2006
0826 GMT [Dow Jones] Sanofi-Aventis (SNY) -1.6% at EUR74.95 following a FDA alert on the group's antibiotic Ketek after three patients suffered severe liver ... - New Ratings

Roundup: Ketek Warning; Harry Potter And Kids' Injuries; Waistline ... Jan 20, 2006
If you take Ketek and feel tired or weak -- or if you become jaundiced, which means to get yellow skin -- report it to your doctor immediately. ... - NBC 10.com,

EMEA Statement On The Safety Of Ketek (telithromycin), Europe Jan 29, 2006
The European Medicines Agency (EMEA) has reviewed cases of serious liver injury associated with the use of Ketek (telithromycin). ... - Medical News Today (press release),

Sanofi's Ketek antibiotic safety profile unchanged Jan 21, 2006
Jan 21, 2006 — PARIS (Reuters) - French drugmaker Sanofi-Aventis SA is standing by its antibiotic Ketek, saying the drug's safety profile remains unchanged ... - ABC News

Ketek Causes Liver Damage Jan 22, 2006
The Ketek antibiotic drug which is used for treating lung and sinus infections has been found to cause liver failure, according to a report. ... - MedIndia,

Antibiotic drug linked to liver damage Jan 25, 2006
Doctors at the Carolinas Medical Center in Charlotte, North Carolina, studied three patients who were administered the drug ’Ketek’ and found liver failure ... - PakTribune.com,

French defend drug after patients develop liver problems Jan 24, 2006
Health authorities in the US are recommending that doctors keep a close eye on patients taking Ketek for signs of liver problems and to stop treatment if ... - News-Medical.net,

OUT OF BREATH Jan 25, 2006
..."This is the strongest," she said, tapping the box labeled Ketek. "It’s very popular.". ... Yet Ketek is not specifically designated to treat the illness. ... - Monitor,

Sanofi Drug Linked to Patient Death, Liver Failure in Report Jan 20, 2006
20 (Bloomberg) -- Sanofi-Aventis SA's antibiotic Ketek, used to treat lung and sinus infections, may be linked to liver damage that resulted in the death of ... - Bloomberg

Sanofi antibiotic ‘risks’ probed Jan 21, 2006
The US Food and Drug Administration urged doctors to watch patients taking the drug, Ketek, for signs of liver problems and to discontinue treatment if ... - Trade Arabia,

FDA Issues Warning on Antibiotic Linked to Liver Damage Jan 23, 2006
The FDA says three people developed severe liver damage after taking the antibiotic Ketek, which is used to treat pneumonia, sinus infections, and bronchitis. ... - FOX News

US says studying liver damage after Sanofi drug Jan 20, 2006
...three cases of serious liver damage, including one that was fatal, that were reported after patients were treated with the Sanofi-Aventis antibiotic Ketek. ... - Reuters.uk,

FDA probing death linked to new antibiotic Jan 20, 2006
One patient at Carolinas Medical Center in Charlotte, NC, died after taking telithromycin, which is marketed as Ketek, researchers at the hospital said. ... - MSNBC

Paris shares down late afternoon as US stocks pare gains, oil ... Jan 23, 2006
...was down 1.64 or 1.25 pct at 74.90 after reports there have been three cases of patients in the US developing liver damage after taking its Ketek drug, which ... - Forbes

Antibiotic May Be Cause Of Liver Problems Jan 20, 2006
...three patients. The antibiotic is telithromycin, also known as Ketek. The Food and Drug Administration approved it in 2004. It's ... - KOLD-TV,

Antibiotic Linked to Liver Damage: Report Jan 21, 2006
The antibiotic Ketek, used to treat lung and sinus infections, may be linked to liver damage that led to the death of a 26-year-old man and transplant surgery ... - HealthCentral.com

Health: Antibiotic, Bacteria, Food Habits And Fish Jan 20, 2006
It is a new antibiotic called Ketek and researchers say one patient taking it has died and two other have liver failure. Ketek is ... - CBS 3,

Paris shares close down, off lows as Wall Street extends gains ... Jan 23, 2006
But it repeated its outperform stance on Sanofi, saying sales of Ketek are expected to be only 600 mln eur -- or 2 pct of operating profit -- in 2010. ... - Forbes

Euroshares open lower after Wall St drop; Philips in focus on ... Jan 23, 2006
STOXX 50 fallers -- down 1.77 pct -- after reports there have been three cases of liver damages in North Carolina, including one death in patients taking Ketek ... - Forbes

Findings may help explain why antibiotic resistance develops so ... Jan 19, 2006
...“We found a brand-new resistance mechanism to an antibiotic called telithromycin,�? he said, referring to Aventis’ drug Ketek, only approved in 2004. ... - MSNBC

UPDATE 1-US says studying liver damage after Sanofi drug Jan 20, 2006
...that were reported after patients were treated with the Sanofi-Aventis (SASY.PA: Quote, Profile, Research)(SNY.N: Quote, Profile, Research) antibiotic Ketek. ... - Reuters

Federal Regulators Probe Possible Death Caused by Novel Antibiotic Jan 21, 2006
A patient at Carolinas Medical Center in Charlotte, NC died after taking Ketek (generic name: telithromycin), according to the Associated Press. ... - All Headline News

Bacteria in soil may show how superbugs develop resistance Jan 22, 2006
They also found a brand-new resistance mechanism to the antibiotic drug Ketek, only approved in 2004. Ketek was designed to overcome ... - News-Medical.net,

FDA Issues Public Health Advisory Concerning Reports of Serious ... Jan 21, 2006
...an article published on Friday in Annals of InternalMedicine reporting that three patients experienced serious liver toxicity after taking Ketek (telithromycin ... - Newsinferno.com,

FDA Investigates Death Linked to Antibiotic Jan 22, 2006
...new antibiotic. The US Food and Drug Administration is investigating whether the drug telithromycin (Ketek) is responsible. A patient ... - ShortNews.com,

Antibiotic Linked To Two Cases Of Liver Failure And Implicated In ... Jan 23, 2006
Three case reports of liver problems after taking the antibiotic telithromycin (Ketek®) are reported in Annals of Internal Medicine. ... - Science Daily (press release)

Three get liver problems after antibiotic Jan 20, 2006
...died, one required and received a liver transplant and the third recovered from drug-induced hepatitis after the antibiotic telithromycin, or Ketek, had been ... - United Press International

Antibiotic may Cause Liver Damage Jan 22, 2006
Researchers at Carolinas Medical Center in Charlotte, NC, report three cases of liver problems in patients taking the antibiotic telithromycin (Ketek). ... - Ivanhoe,

Bugs may be 'born' resistant to drugs Jan 19, 2006
..."We found a brand-new resistance mechanism to an antibiotic called telithromycin," he says, referring to Aventis' drug Ketek, which has only recently been ... - ABC Science Online,

Antibiotic-Resistant Bacteria May Aid Drug Search, Study Says Jan 19, 2006
The research, headed by Gerard Wright, head of biochemistry and biomedical sciences at McMaster, included drugs as new as Ketek and Tygacil. ... - Bloomberg

EMEA - Committee For Medicinal Products For Human Use - 23-26 ... Jan 29, 2006
Following a preliminary review of cases of serious liver injury associated with the use of Ketek (telithromycin), the CHMP has asked the marketing ... - Medical News Today (press release),

On the Move: Philips, UBS, Sanofi-Aventis Jan 23, 2006
Separately, the FDA opened a probe into the company's Ketek drug after three cases of serious liver damage. RHODIA was up €0.22 to €2.18. ... - BusinessWeek

Bourses seen sharply lower Jan 23, 2006
Sanofi-Aventis, the French drugmaker, said its drug Ketek's safety profile remained unchanged even though US regulators said late on Friday they were reviewing ... - MSNBC

HealthWatch For Jan. 20, 2006 Jan 20, 2006
The warning will be published in the Annals of Internal Medicine. The antibiotic is called Telithromycin and goes by the brand name of Ketek. ... - NBC5.com,

Geo-Political Tensions Propel Euro Jan 23, 2006
Sanofi-Aventis, the French drug maker, fell 1.6% to €74.95 after its drug Ketek was tied to three cases of serious liver damage in the US. ... - Daily FX,

Chiron wins EU approval for IV antibiotic Jan 24, 2006
The others are Pfizer's Zyvox (linezolid) and Sanofi-Aventis' Ketek (telithromycin; which hit the headlines itself yesterday after being linked to liver ... - Pharma Times (subscription),

Dr. Gaff's Column Nov 28, 2005
Zocor, Vytorin) with itraconazole (Sporanox), ketoconazole (Nizoral), erythromycin, clarithromycin (Biaxin), telithromycin (Ketek), protease inhibitors (HIV ... - KPCnews.com,

Cognet-X Inc. - Managed Care Executives Report Pfizer Inc. ... Nov 30, 2005
...aid Ambien CR in the third quarter; promotion for that brand as well as increased contacts for the antihistamine Allegra and the antibiotic Ketek moved Sanofi ... - Genetic Engineering News,

Sanofi-aventis Third Quarter 2005: Adjusted EPS(1) up 27.4%, Net ... Nov 7, 2005
Ketek(R) Third-quarter net sales of Ketek(R) were euro 38 million, 7.3% lower than in the third quarter of 2004, when the product was launched in the United ... - PR Newswire (press release),

Sanofi-aventis Third Quarter 2005: Adjusted EPS(1) up 27.4%, Net ... Nov 7, 2005
Third-quarter net sales of Ketek® were euro 38 million, 7.3% lower than in the third quarter of 2004, when the product was launched in the United States. ... - Yahoo! News (press release)

Sports Calendar Oct 29, 2005
Please e-mail Kelly Techo at ketek@charter.net for more information. Details will be provided on the www.pryaa.com Web site soon. Nov. ... - Gwinnett Daily Post,

Sports Calendar 11 Oct 2005
Please e-mail Kelly Techo at ketek@charter.net for more information. Details will be provided on the www.pryaa.com Web site soon. Nov. ... - Gwinnett Daily Post,

Microbiological activity of telithromycin against Streptococcus ... Sep 21, 2005
New data demonstrates that in vitro activity of Ketek (telithromycin) remained consistently high on S. pneumoniae with at least 99.8% of the isolates being ... - Canada NewsWire (press release),

Vytorin, Zocor Label Change Seen 'Immaterial' Aug 25, 2005
...and Drug Administration's Medwatch System recently posted a label change for both Vytorin and Zocor, which warns that combination use with Ketek can increase ... - Forbes

Antibacterial hope lies in clever drugs for superbugs Aug 19, 2005
...new products. For example, despite high hopes, Sanofi-Aventis' Ketek has so far failed to meet analysts' expectations. Despite its ... - Pharmaceutical Business Review

Antibacterials: Clever Drugs for ‘Superbugs’ Aug 18, 2005
...“For example, despite the high expectations, Ketek, launched in France in 2002 for the treatment of respiratory tract infections caused by resistant pathogens ... - PharmaLive.com (press release),

University professor pins hope on drug to fight MRSA Aug 15, 2005
The industry is caught in a catch-22. Testing the drugs is expensive. For instance, Sanofi Aventis's new antibiotic, Ketek, was trialled in 24,000 patients. ... - Guardian Unlimited,